JP2011507860A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507860A5
JP2011507860A5 JP2010539517A JP2010539517A JP2011507860A5 JP 2011507860 A5 JP2011507860 A5 JP 2011507860A5 JP 2010539517 A JP2010539517 A JP 2010539517A JP 2010539517 A JP2010539517 A JP 2010539517A JP 2011507860 A5 JP2011507860 A5 JP 2011507860A5
Authority
JP
Japan
Prior art keywords
connexin
composition
polynucleotide
medicament
scar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010539517A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011507860A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/014025 external-priority patent/WO2009085274A2/en
Publication of JP2011507860A publication Critical patent/JP2011507860A/ja
Publication of JP2011507860A5 publication Critical patent/JP2011507860A5/ja
Pending legal-status Critical Current

Links

JP2010539517A 2007-12-21 2008-12-22 異常瘢痕または過剰瘢痕の治療のための抗コネキシンポリヌクレオチドおよび抗コネキシンペプチドの使用 Pending JP2011507860A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US883707P 2007-12-21 2007-12-21
PCT/US2008/014025 WO2009085274A2 (en) 2007-12-21 2008-12-22 Use of anti-connexin polynucleotides and peptides for the treatment ofabnormal or excessive scars

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014248303A Division JP2015057430A (ja) 2007-12-21 2014-12-08 異常瘢痕または過剰瘢痕の治療のための抗コネキシンポリヌクレオチドおよび抗コネキシンペプチドの使用

Publications (2)

Publication Number Publication Date
JP2011507860A JP2011507860A (ja) 2011-03-10
JP2011507860A5 true JP2011507860A5 (enExample) 2013-04-25

Family

ID=40824958

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010539517A Pending JP2011507860A (ja) 2007-12-21 2008-12-22 異常瘢痕または過剰瘢痕の治療のための抗コネキシンポリヌクレオチドおよび抗コネキシンペプチドの使用
JP2014248303A Pending JP2015057430A (ja) 2007-12-21 2014-12-08 異常瘢痕または過剰瘢痕の治療のための抗コネキシンポリヌクレオチドおよび抗コネキシンペプチドの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014248303A Pending JP2015057430A (ja) 2007-12-21 2014-12-08 異常瘢痕または過剰瘢痕の治療のための抗コネキシンポリヌクレオチドおよび抗コネキシンペプチドの使用

Country Status (7)

Country Link
US (1) US20130184220A1 (enExample)
EP (1) EP2252320A2 (enExample)
JP (2) JP2011507860A (enExample)
AU (1) AU2008343755A1 (enExample)
CA (1) CA2710232A1 (enExample)
WO (1) WO2009085274A2 (enExample)
ZA (1) ZA201005221B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101573131B (zh) 2005-02-03 2017-12-01 科达治疗有限公司 抗‑连接蛋白化合物及其治疗应用
EA015304B1 (ru) 2006-08-03 2011-06-30 Нитек Фарма Аг Лечение ревматоидного заболевания глюкокортикоидами с отсроченным высвобождением
WO2009085270A2 (en) 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of inhibitors of c0nnexin43 for treatment of fibrotic conditions
US9999702B2 (en) * 2010-04-09 2018-06-19 Kci Licensing Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
CN104271142B (zh) 2012-03-01 2017-07-04 福斯特斯特林研究公司 含有α连接蛋白C‑末端(ACT)肽的局部凝胶
WO2015019124A1 (en) * 2013-08-05 2015-02-12 Societe De Developpement Et De Recherche Industrielle Molecular targets for the prevention and/or treatment of fibrosis, hypertrophic scars or keloids
JP6360332B2 (ja) 2014-03-20 2018-07-18 テルモ株式会社 送液ポンプ
CA2958879A1 (en) 2014-08-22 2016-02-25 Auckland Uniservices Limited Channel modulators
CA2961894C (en) 2014-09-19 2023-12-12 Memorial Sloan-Kettering Cancer Center Methods for treating brain metastatis using gap junction inhibitors
JP6716841B2 (ja) * 2016-02-10 2020-07-01 株式会社アルチザンラボ 止血材
EP3452072A4 (en) * 2016-05-03 2020-04-15 University of Auckland NEW PEPTIDES AND PEPTIDOMIMETICS
JP7495230B2 (ja) 2017-04-28 2024-06-04 オークランド ユニサービシズ リミテッド 処置方法および新規構築物
CN110997018A (zh) 2017-08-01 2020-04-10 医疗发明株式会社 止血材料及含有其的创伤敷料
WO2019046678A1 (en) * 2017-09-01 2019-03-07 Excel Med, Llc PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CHOLOIDS AND USES THEREOF
JP7393780B2 (ja) * 2019-08-19 2023-12-07 学校法人順天堂 ギャップ結合機能制御剤のスクリーニング方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965618A (en) * 1997-11-17 1999-10-12 Perricone; Nicholas V. Treatment of scar tissue using lipoic acid
PT2314321E (pt) * 1999-01-27 2014-09-26 Coda Therapeutics Inc Elemento de encaminhamento de um fluido de refrigeração de uma ferramenta de corte e processo para este encaminhamento
JP4682129B2 (ja) * 2003-06-09 2011-05-11 アセンド セラピュティクス インコーポレイテッド 4−ヒドロキシタモキシフェンによる過剰瘢痕化の治療及び予防
JP5097891B2 (ja) * 2005-09-20 2012-12-12 株式会社ポーラファルマ 皮膚外用剤
KR20150072458A (ko) * 2006-11-15 2015-06-29 코다 테라퓨틱스, 인크. 상처 치유를 위한 개선 방법 및 조성물
EP2245158A2 (en) * 2007-12-11 2010-11-03 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments

Similar Documents

Publication Publication Date Title
JP2011507860A5 (enExample)
JP2011506447A5 (enExample)
JP2011507861A5 (enExample)
JP2011507858A5 (enExample)
JP2011507855A5 (enExample)
JP2025128190A5 (enExample)
AU2003287423B2 (en) Methods and systems for enabling and stabilizing tooth movement
JP2019196370A5 (enExample)
RU2009122370A (ru) Улучшенные способы и композиции для заживления ран
JP2011256204A5 (enExample)
US20050186526A1 (en) Methods and systems for enabling and stabilizing tooth movement
US20150343013A1 (en) Methods of treating neuropathic pain
SI2999785T1 (en) SERPINA1 IRNA assemblies and procedures for their use
JP2015057430A (ja) 異常瘢痕または過剰瘢痕の治療のための抗コネキシンポリヌクレオチドおよび抗コネキシンペプチドの使用
JP2007537288A5 (enExample)
JP2011507862A5 (enExample)
JP2020524129A (ja) 再発膠芽腫(rgbm)の治療方法
JP2015083606A (ja) 線維症性の状態の治療のための抗コネキシンポリヌクレオチド剤と組み合わせた抗コネキシンポリペプチド剤の使用
JP2009544585A5 (enExample)
JP2004508280A5 (enExample)
JP2004501870A (ja) ガン患者における化学療法の副作用を軽減させる方法
JP2018521669A (ja) 治療用オリゴヌクレオチド
Li et al. Role of paraventricular angiotensin AT1 receptors in salt-sensitive hypertension in mRen-2 transgenic rats
CN101896190A (zh) 用α胸腺肽和抗细胞毒性T淋巴细胞相关抗原4(CTLA4)的抗体的组合治疗黑素瘤
Bufalari et al. Preemptive carprofen for peri-operative analgesia in dogs undergoing Tibial Plateau Leveling Osteotomy (TPLO): a prospective, randomized, blinded, placebo controlled clinical trial